Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03040492 · ClinicalTrials.gov registry record
Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk
A clinical trial of Skin Cancer, Non-Melanoma, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03040492 is a study of Skin Cancer, Non-Melanoma that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03040492, a study of Skin Cancer, Non-Melanoma, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to discover whether certain Vitamin D Receptor (VDR) gene polymorphisms are associated with an increased risk of cutaneous basal cell carcinoma (BCC) and/or cutaneous squamous cell carcinoma (SCC) in an Alabama population. Participant demographic information such as physical characteristics (e.g., ethnicity), family history, and cancer diagnosis will be collected in order to determine if there are relationships between the gene polymorphisms, cancer diagnosis, and these characteristics.
Conditions Studied
Study Locations (1)
Alabama
- The Kirklin Clinic - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2012-10-31 |
| Est. Completion | 2017-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03040492
The ClinicalTrials.gov registry entry for NCT03040492 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Skin Cancer, Non-Melanoma appearing as the primary indexed condition, and to 0 interventions.
NCT03040492 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT03040492 about?
NCT03040492 is a clinical study titled "Vitamin D Receptor Polymorphisms and Non-Melanoma Skin Cancer Risk". The purpose of this study is to discover whether certain Vitamin D Receptor (VDR) gene polymorphisms are associated with an increased risk of cutaneous basal cell carcinoma (BCC) and/or cutaneous squamous cell carcinoma (SCC) in an Alabama population. Participant demographic information such as phys...
What is the current status of trial NCT03040492?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2012-10-31. Estimated completion is 2017-06-30.
What conditions does trial NCT03040492 study?
This clinical trial studies the following conditions: Skin Cancer, Non-Melanoma.
Who is sponsoring clinical trial NCT03040492?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03040492 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Cancer, Non-Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.